Individual investors in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) are its biggest bettors, and their bets paid off as stock gained 20% last week

Key Insights Corvus Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...

Related Keywords

Richard Miller ,Corvus Pharmaceuticals ,Corvus Pharmaceuticals Inc ,Orbimed Advisors ,Institutional Ownership Tell Us About Corvus Pharmaceuticals ,Institutional Investors ,Shareholders ,Ndividual Investors ,